Genedrive Share Discussion Threads

[bunz3] 09/2/2021 13:23

if £2 seen before Friday ,then might see some selling ,will not be selling any even if some others do

[bunz3] 09/2/2021 13:19

large buyer / buyers liking the dips Today

some nice sized tranches being bought

[bunz3] 09/2/2021 13:12

and again nice buy

[bunz3] 09/2/2021 13:07

Hooded Claw ,seems to be so many buyers loading if any sells ,

[hooded claw] 09/2/2021 13:04

They keep trying the odd shake but very few weak holders now

[richardp19] 09/2/2021 13:01

Lovely this isNext news about beck man and it's going parabolic

[hooded claw] 09/2/2021 12:59

Sellsell, spot on with the prediction;)

[bunz3] 09/2/2021 12:59

like how sellers shares being bought up

[bunz3] 09/2/2021 12:55

with this number of buys coming in ,are more institutions buyers helping move this share price up

[bunz3] 09/2/2021 12:46

Had thought £2 might be seen by Friday

with this buying ,might be seen before then


,better to see a gradual rise ,with sellers cleared at each level .

[awise355] 09/2/2021 12:41

Just people like you as me I'd say, small amount of shares issued. Did this last year

[hooded claw] 09/2/2021 12:40

Still way too cheap IMHO

[swerves1] 09/2/2021 12:40

Looks like an institution getting in!

[stumbleupon] 09/2/2021 12:39

There is a possibility and why not...it could smash through £1.50 today

[bunz3] 09/2/2021 12:36

looks to be moving towards 1,40
now 1,35 being paid

[bunz3] 09/2/2021 12:24

are more institutions now loading up at gdr



with this amount of buying again Today



have more institutions be came aware of the




Distribution agreement with Beckman Coulter

[sellsell] 09/2/2021 12:23

Being offered 132.9p for 10000 shares. This is about to move

[jjmills56] 09/2/2021 12:20

RNS 17/11 shows final results sbd states at 31/10/20 unaudited cash stood at £5.1m after securing long lead time supplies and building initial stocks ..... hopefully this will last until first sales replenish the b/sheet .

[bunz3] 09/2/2021 12:17

craffert,Thanks for more good research ,


good to see more posters now back at gdr share board


good to see posters who have knowledge of gdr posting



Also good to see new investors posting as wsll

[theaviator] 09/2/2021 12:15

Lol I saw it break and missed it, true. Oh well. Let's see. Hope it goes on up for you guys.GL

[craffert] 09/2/2021 12:10

Funding not an issue here. Genedrive operating cash burn £4.8mn per annum last year, finished the year (June 20) with net cash of £8.2mn and an R&D tax credit of £1mn owing so cash now probably around £6mn mark. And no debt. What's more, explosive growth in sales via Beckman can easily be bank i/d funded to bring fwd the cash for working capital cycle. There are risks, but placing isn't one of them IMHO

[bunz3] 09/2/2021 12:08

Hooded Claw, Good to see you posting ,you look to have researched gdr well


still researching here yet myself


so appreciate reading posts from people who look to have dome more research

than myself



the more I research the more I like this share,



enjoyed a nice move up with ncyt from £2,20 up to £12


personly more excited with gdr



even the potential for USA sales if some announced soon


then thinking a nice rerate


a share have read with no debt ,money in bank


and so many good rns

[hooded claw] 09/2/2021 12:02

Bunz, most of my buys were at higher risk (but MUCH lower than present) on the chance that a deal would materialise between GDR and BC.28th Jan was a big day but I already felt a deal was coming as I heard of the NDA and double checked with GDR.The market doesn't realise the full potential and is waiting for numbers but you can tell the numbers will be big following information last year and from DB interview where he stated 'material and significant'.

[bunz3] 09/2/2021 12:01

swerves1


To me this still so undervalued



("genedrive" or the "Company")



Genedrive® 96 SARS-CoV-2 Kit approved in South Africa



genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that the Company's Genedrive® 96 SARS-CoV-2 Kit has received approval from the South African Health Products Regulatory Authority. The Genedrive® kit was submitted for evaluation in June 2020.



Under the approval, the Kit can now be distributed and sold within South Africa. Genedrive products are supplied in the country, and more broadly within Africa, via the Sysmex EMEA organisation.



Since the original evaluation, genedrive has expanded the number of PCR platforms and RNA isolation kit providers which are validated for the Company's Kit. This is important for markets such as South Africa where high testing volumes are supported by the prevalence of automated/robotic RNA extraction instruments, and the variety of testing platforms is diverse owing to a split between public and private testing facilities.


David Budd, Chief Executive Officer of genedrive plc, said "This is an important milestone in the commercialisation of our COVID-19 Kit in the region. South Africa is a key territory for our distributors and this approval will now provide an acceleration of commercial sales activity in the area."